Fidelity Investments
FMED icon

Fidelity Investments’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Fidelity Investments’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18M Sell
732,972
-28
-0% -$728 ﹤0.01% 1823
2025
Q4 		$19.8M Buy
733,000
+5
+0% +$135 ﹤0.01% 1779
2025
Q3 		$18.3M Sell
732,995
-43
-0% -$1.04K ﹤0.01% 1780
2025
Q2 		$17.6M Buy
733,038
+95,250
+15% +$2.22M ﹤0.01% 1732
2025
Q1 		$15.1M Sell
637,788
-22,576
-3% -$570K ﹤0.01% 1783
2024
Q4 		$16.3M Sell
660,364
-3,236
-0.5% -$83.4K ﹤0.01% 1793
2024
Q3 		$17.4M Sell
663,600
-66,239
-9% -$1.67M ﹤0.01% 1756
2024
Q2 		$17.6M Sell
729,839
-10,841
-1% -$262K ﹤0.01% 1696
2024
Q1 		$18.9M Buy
740,680
+20,744
+3% +$513K ﹤0.01% 1680
2023
Q4 		$17.4M Sell
719,936
-18,061
-2% -$392K ﹤0.01% 1672
2023
Q3 		$16.3M Sell
737,997
-19,697
-3% -$472K ﹤0.01% 1660
2023
Q2 		$19M Buy
+757,694
New +$19.1M ﹤0.01% 1661

Other funds holding FMED

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
BW
BXM Wealth Englewood, Colorado $184M AUM 36.28% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments's FMED Position: Q1 2026 in Review

Fidelity Investments reduced its Fidelity Disruptive Medicine ETF (FMED) stake by 0% in Q1 2026, selling an estimated $728 and leaving 732,972 shares worth $18M. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Fidelity Investments first reported a position in FMED in Q2 2023 and has held it in 12 quarters since. The position peaked at $19.8M in Q4 2025. 11 funds tracked by Wall St. Rank hold FMED as of Q1 2026.

  • Fidelity Investments held 732,972 shares of Fidelity Disruptive Medicine ETF worth $18M as of Q1 2026.
  • Fidelity Investments sold 28 Fidelity Disruptive Medicine ETF shares in Q1 2026, an estimated $728.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1823 holding.
  • Fidelity Investments first reported a position in Fidelity Disruptive Medicine ETF in Q2 2023 and has held it in 12 quarters since.
  • Fidelity Investments's Fidelity Disruptive Medicine ETF position peaked at $19.8M in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.